COVID-19 modifications of offseason and preseason training for NFL athletes are associated with increased risk of regular season injuries

ABSTRACT

Objectives

COVID-19 altered National Football League (NFL) player and team training during the 2020 offseason. All preseason games were cancelled resulting in absence of game play before the first week of the regular season. Thus, concerns exist regarding injury susceptibility of players during regular season games. The purpose of this study was to evaluate and compare injury rates during the 2020 NFL season versus injury rates from the unaffected 2017–2019 seasons. We hypothesized there would be an increased injury rate and an increased rate of season ending injuries during the modified 2020 season.

Methods

The NFL’s public injury database was queried to identify players placed on the injury lists throughout the 2017–2020 seasons. All players listed as “out” and on the injured reserve due to physical injury were included in the data set. For further stratification, injury incidence was separated based on position. Time missed due to COVID-19 illness was not included. Injury rates were expressed as injuries per 1000 athlete exposures (AE).

Results

Overall, 893 individual players missed games due to injury during the 2020 NFL regular season compared to an average of 743 over the 2017–2019 seasons. Defensive players at all positions had a statistically significant increase in injury incidence from an average of 7.54 to 10.20 injuries per 1000 AE. Defensive backs were most affected with a 46% increase in players injured. There was no statistically significant difference in season ending injuries for any position.

Conclusions

The COVID-19 stricken 2020 NFL regular season saw an increased rate and incidence of injuries. Specifically, defensive players had a higher incidence of injury overall with defensive backs experiencing the greatest increase in injury rates.

KEYWORDS:

• Injury
• National Football League
• Football
• COVID-19

Declaration of interest

There were no current or potential conflicts of interests that impacted the quality of this work.

Additional information

Funding

There were no financial, pharmaceutical, or industry support for this project. The authors fully disclose that there was no additional funding from any of the following organizations including National Institutes of Health (NIH), Wellcome Trust, Howard Hughes Medical Institute (HHMI) or any other organizations